0001607062-22-000004.txt : 20220107
0001607062-22-000004.hdr.sgml : 20220107
20220107172220
ACCESSION NUMBER: 0001607062-22-000004
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220105
FILED AS OF DATE: 20220107
DATE AS OF CHANGE: 20220107
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PETKANAS DEAN
CENTRAL INDEX KEY: 0000944235
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55657
FILM NUMBER: 22518979
MAIL ADDRESS:
STREET 1: 3805 OLD EASTON ROAD
CITY: DOYLESTOWN
STATE: PA
ZIP: 18902
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEUROPATHIX, INC.
CENTRAL INDEX KEY: 0001615999
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 462645343
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3805 OLD EASTON ROAD
CITY: DOYLESTOWN
STATE: PA
ZIP: 18902
BUSINESS PHONE: 858-883-2642
MAIL ADDRESS:
STREET 1: 3805 OLD EASTON ROAD
CITY: DOYLESTOWN
STATE: PA
ZIP: 18902
FORMER COMPANY:
FORMER CONFORMED NAME: Neuropathix, Inc.
DATE OF NAME CHANGE: 20201112
FORMER COMPANY:
FORMER CONFORMED NAME: Kannalife Inc
DATE OF NAME CHANGE: 20181113
FORMER COMPANY:
FORMER CONFORMED NAME: TYG Solutions Corp.
DATE OF NAME CHANGE: 20140821
4
1
ownership.xml
X0306
4
2022-01-05
0
0001615999
NEUROPATHIX, INC.
NPTX
0000944235
PETKANAS DEAN
3805 OLD EASTON ROAD
DOYLESTOWN
PA
18902
1
1
1
0
Chief Executive Officer
Common Stock
2022-01-05
4
S
0
89000
0.047
D
24770029
I
See Note
Common Stock
2022-01-06
4
S
0
120000
0.051
D
24650029
I
See Note
Common Stock
2022-01-07
4
S
0
41000
0.046
D
24609029
I
See Note
Common Stock
2022-01-07
4
G
0
300000
0.00
D
24309029
I
See Note
Common Stock
2022-01-07
4
G
0
250000
0.00
D
24059029
I
See Note
The sales reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person.
These shares were sold in multiple transactions at prices falling within those ranges set forth in footnotes (3) and (5) of this Form 4. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the relevant footnotes.
These shares were sold in multiple transactions at prices ranging from $0.045 to $0.050, inclusive.
These shares were sold in multiple transactions at prices ranging from $0.045 to $0.050, inclusive.
Aggregate amount of shares beneficially owned by the reporting person includes shares held by him directly as well as indirectly through Powerlife Phytomedical, LLC and Golden Gate Capital Partners, LLC. The reporting person disclaims beneficial ownership of the securities held by Powerlife Phytomedical, LLC and Golden Gate Capital Partners, LLC, except to the extent of his pecuniary interest therein.
Represents a gift of shares by Golden Gate Capital Partners, LLC.
/s/ Dean Petkanas
2022-01-07